ERBB2 and breast cancer: A recent study failed to show a significant reduction in breast cancer mortality in patients treated with metformin [14] but some fairly small studies have reported a beneficial effect of metformin use on survival in patients with human epidermal growth factor receptor-2 (HER2)-positive tumors [15].